— Know what they know.
Not Investment Advice

3386.T JPX

Cosmo Bio Company,Limited
1W: +0.9% 1M: +0.6% 3M: +2.1% YTD: -4.6% 1Y: +6.5% 3Y: +42.5% 5Y: +19.4%
¥1,288.00 ($8.15)
+34.00 (+2.71%)
 
Weekly Expected Move ±1.5%
¥1216 ¥1235 ¥1254 ¥1273 ¥1292
JPX · Healthcare · Medical - Diagnostics & Research · Tech Score Buy · Power 66 · ¥7.1B mcap · 2M float · 0.217% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap¥7.1B ($45.0M)
52W Range1083-1486
Volume3,100
Avg Volume4,718
Beta0.17
Dividend¥50.00
Analyst Ratings
No analyst coverage
Company Info
CEONorihiko Shibayama
Employees182
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date2005-09-27
Toyo-Ekimae Building
Tokyo, TY 135-0016
JP
81 3 5632 9600
About Cosmo Bio Company,Limited

Cosmo Bio Company, Limited is a key player in the life science research sector, involved in the global import, export, manufacturing, marketing, and distribution of essential biotools. Their extensive product line includes biochemical reagents, specialized kits, scientific instruments, analytical software, and diagnostic products. Among their research reagents, they offer a wide spectrum such as antibodies, antigens, bioactive substances, enzymes, peptides, amino acids, various chemicals, carbohydrates, lipids, and components derived from viruses and bacteria. They also provide crucial detection reagents, cell and tissue culture systems, and gene analysis solutions. In terms of instrumentation, Cosmo Bio supplies electrophoresis apparatuses, cell culture labware, gene manipulation systems, and data analysis software. Beyond products, the company delivers valuable services like drug discovery support, custom research, and clinical diagnostics. A significant part of their operation involves the development and manufacturing of proprietary cell and cell culture products. This includes a range of specialized cells such as adipose tissue, bone, cartilage, tooth, pancreas, liver function, cardiovascular, immune, and mesenchymal stem cells, in addition to feeder cells, tumor cell lines, coating reagents, and macrophage-related products. They also produce various assay kits for measurement, staining, detection, and purification. Furthermore, they offer specialized biotechnology research equipment, including constant-temperature transport containers, aluminum block heat insulation devices, and dew condensation prevention glass plates, alongside consigned services for custom peptide synthesis and antibody production. Serving a diverse clientele of laboratories, research institutes, and life science education and testing organizations, Cosmo Bio distributes its products through its own outlets in Japan and an international network of sales agents. The company was founded in Tokyo, Japan, in 1978, where its headquarters remain.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms